Skip to content

Nuvalent, Inc. NUVL Prepaid & Other Current

Prepaid & Other Current at other companies

Summit Therapeutics logo
Summit TherapeuticsSMMT
$17.55M+92.5%
Exelixis logo
ExelixisEXEL
$75.88M+29.3%
Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
$59.83M+87.5%
Incyte logo
IncyteINCY
$301.31M+42.4%
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$149.7M-0.4%
ALN
Alnylam PharmaceuticalsALNY

Other financials

Income statement

See full
Operating income-$119.4M-25.9%
Net income-$109.3M-29.2%
EPS (diluted)-$1.39-17.8%

Balance sheet

See full
Cash & equivalents$159.7M+32.2%
Total equity$1.2B+16.2%
Total assets$1.3B+20.4%

Cash flow

See full
Operating cash flow-$92.4M-68.5%

Valuation

See full
Market cap$9.77B+58.6%

Returns & leverage

See full
Return on equity-41.2%+7.5pp
Current ratio16.1×+1.7×

Where this comes from

Reported directly by Nuvalent, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.

The official record: Nuvalent, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvalent, Inc.'s prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nuvalent, Inc.'s prepaid & other current?
Nuvalent, Inc. (NUVL) reported prepaid & other current of $20.46M in Q1 2026.
How has Nuvalent, Inc.'s prepaid & other current changed year-over-year?
Nuvalent, Inc.'s prepaid & other current increased by 53.5% year-over-year, from $13.33M to $20.46M.
What is the long-term trend for Nuvalent, Inc.'s prepaid & other current?
Over 4 years (2021 to 2025), Nuvalent, Inc.'s prepaid & other current has grown at a 81.9% compound annual growth rate (CAGR), from $5.64M to $61.66M.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.